Induction of vascular leakage and blood pressure lowering through kinin release by a serine proteinase from Aeromonas sobria

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8723-8729

  Imamura, Takahisa ^a   Kobayashi, Hidemoto ^b   Khan, Rasel ^b   Nitta, Hidetoshi ^a   Okamoto, Keinosuke ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ B2 RECEPTOR; HISTAMINE H1 RECEPTOR; KININ; KININOGEN; PREKALLIKREIN; SERINE PROTEINASE; SOYBEAN TRYPSIN INHIBITOR;

AEROMONAS SOBRIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BLOOD PRESSURE REGULATION; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME RELEASE; FATALITY; FEMALE; GUINEA PIG; KALLIKREIN KININ SYSTEM; MALE; MOLECULAR WEIGHT; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 33845405561     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8723     Document Type: Article

References (53)

1. Jones, B. L., and M. H. Wilcox. 1995. Aeromonas infection and their treatment. J. Antimicrob. Chemother. 35: 453-461.
2. Janda, J. M., and R. Brenden. 1987. Importance of Aeromonas sobria in Aeromonas bacteremia. J. Infect. Dis. 155: 589-591.
3. Farraye, F. A., M. A. Peppercorn, P. S. Ciano, and W. N. Kavesh. 1989. Segmental colitis associated with Aeromonas hydrophila. Am. J. Gastroenterol. 84: 436-438.
4. Deutsch, S. F., and W. Wedzina. 1997. Aeromonas sobria-associated left-sided segmental colitis. Am. J. Gastroenterol. 92: 2104-2106.
5. Schiavano, G. F., F. Bruscolini, A. Albano, and G. Brandi. 1998. Virulence factors in Aeromonas spp. and their association with gastrointestinal disease. New Microbiol. 21: 23-30.
6. Janda, J. M., and S. L. Abbott. 1998. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin. Infect. Dis. 27: 332-344.
7. Janda, J. M., and S. L. Abbott. 1996. Human pathogens. In The Genus Aeromonas. B. Austin, M. Altwegg, P. J. Gosling, and S. Joseph, eds. John Wiley & Sons, Chichester, pp. 151-173.
8. Janda, J. M., L. S. Guthertz, R. P. Kokka, and T. Shimada. 1994. Aeromonas species in septicemia: laboratory characteristics and clinical observations. Clin. Infect. Dis. 19: 77-83.
9. Duthie, R., T. W. Ling, A. F. B. Cheng, and G. L. French. 1995. Aeromonas septicemia in Hong Kong: species distribution and associated diseases. J. Infect. Dis. 30: 241-244.
10. Lin, S.-H., S.-D. Shieh, Y.-F. Lin, E. De Bauer, H. W. Van Landuyt, B. Gordts, and J. R. Boelaert. 1996. Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine. Am. J. Kidney Dis. 27: 733-735.
11. Cristofaro, P., and S. M. Opal. 2005. The Toll-like receptors and their role in septic shock. Expert Opin. Ther. Targets 7: 603-612.
12. Cochrane, C. G., and J. H. Griffin. 1982. The biochemistry and pathophysiology of the contact system of plasma. Adv. Immunol. 33: 241-306.
13. Smith-Erichsen, N., A. O. Aasen, M. J. Gallimore, and E. Amundsen. 1982. Studies of components of the coagulation systems in normal individuals and septic shock patients. Circ. Shock 9: 491-497.
14. Kalter, E. S., M. R. Daha, J. W. ten Carte, J. Verhoef, and B. N. Bouma. 1985. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J. Infect. Dis. 151: 1019-1027.
15. Hesselvik, J. F., M. Blombäck, B. Brodin, and R. Maller. 1989. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit. Care Med. 17: 724-733.
16. Pixley, R. A., S. Zellis, P. Bankes, R. A. DeLa Cadena, J. D. Page, C. F. Scott, J. Kappelmayer, E. G. Wyshock, J. J. Kelly, and R. W. Colman. 1995. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit. Care Med. 23: 41-51.
17. Regoli, D., and J. Barabé. 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32: 1-46.
18. Pixley, R. A., R. A. DeLa Cadena, J. D. Page, N. Kaufman, E. G. Wyshock, W. R. Colman, A. Chang, and F. B. Taylor, Jr. 1992. Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am. J. Pathol. 140: 897-906.
19. Pixley, R. A., R. A. DeLa Cadena, J. D. Page, N. Kaufman, E. G. Wyshock, A. Chang, F. B. Taylor, Jr., and R. W. Colman. 1993. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J. Clin. Invest. 91: 61-68.
20. Janda, J. M. 1991. Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas. Clin. Microbiol. Rev. 4: 397-410.
21. Imamura, T., R. N. Pike, S. Potempa, and J. Travis. 1994. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 94: 361-367.
22. Imamura, T., J. Potempa, R. N. Pike, and J. Travis. 1995. Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect. Immun. 63: 1999-2003.
23. Imamura, T., S. Tanase, G. Szmyd, A. Kozik, J. Travis, and J. Potempa. 2005. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 201: 1669-1676.
24. Janda, J. M., M. Reitano, and E. J. Bottone. 1984. Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J. Clin. Microbiol. 19: 44-47.
25. Daily, O. P., S. W. Joseph, J. C. Coolbaugh, R. I. Walker, B. R. Merrell, D. M. Rollins, R. J. Seidler, R. R. Colwell, and C. R. Lissner. 1981. Association of Aeromonas sobria with human infection. J. Clin. Microbiol. 13: 769-777.
26. Okamoto, K., T. Nomura, M. Hamada, T. Fukuda, Y. Noguchi, and Y. Fujii. 2000. Production of serine protease of Aeromonas sobria is controlled by the protein encoded by the gene lying adjacent to the 3′ end of the protease gene. Microbiol. Immunol. 44: 787-798.
27. Yokoyama, R., Y. Fujii, Y. Noguchi, T. Nomura, M. Akita, K. Setsu, S. Yamamoto, and K. Okamoto. 2002. Physicochemical and biological properties of an extracellular serine protease of Aeromonas sobria. Microbiol. Immunol. 46: 383-390.
28. Morita, T., H. Kato, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara. 1977. New fluorogenic substrates for α-thrombin, factor Xa, kallikreins, and urokinase. J. Biochem. 82: 1495-1498.
29. Kawabata, S., T. Miura, T. Morita, H. Kato, K. Fujikawa, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara. 1988. Highly sensitive peptid-4-methylcoumaryl-7-amide substrates for blood clotting proteases and trypsin. Eur. J. Biochem. 172: 17-25.
30. Udaka, K., Y. Takeuchi, and H. Z. Movat. 1970. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133: 1384-1387.
31. 8]bradykinin). Eur. J. Pharmacol. 210: 115-120.
32. Wirth, K., F. J. Hock, U. Albus, W. Linz, H. G. Alpermann, H. Anagnostopoulos, S. Henke, G. Breipohl, J. Knolle, and B. A. Schölkens. 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102: 774-777.
33. Wuepper, K. D., and C. G. Cochrane. 1972. Plasma prekallikrein: isolation, characterization, and mechanism of activation. J. Exp. Med. 135: 1-20.
34. Imamura, T., T. Yamamoto, and T. Kambara. 1984. Guinea pig plasma kallikrein as a vascular permeability enhancement factor, its dependence on kinin generation and regulation mechanisms in vivo. Am. J. Pathol. 115: 92-101.
35. Müller-Esterl, W. 1986. Kininogens. in Methods of Enzymatic Analysis: Proteins and Peptides, Vol. 9, 3rd Ed. H. U. Bergmeyer, J. Bergmeyer, and M. Graβ1, eds. VCH, Weinheim, pp. 304-316.
36. Kobayashi, H., E. Takahasni, K. Oguma, Y. Fujii, H. Yamanaka, T. Negishi, S. Arimoto-Kobayashi, T. Tsuji, and K. Okamoto. 2006. Cleavage specificity of the serine protease of Aeromonas sobria, a member of the kexin family of subtilases. FEMS Microb. Lett. 256: 165-170.
37. Chung, D. W., K. Fujikawa, B. A. MacMullen, and E. W. Davie. 1986. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 25: 2410-2417.
38. Takagaki, Y., N. Kitamura, and S. Nakanishi. 1985. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. J. Biol. Chem. 260: 8601-8609.
39. Imamura, T., J. Potempa, and J. Travis. 2000. Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis. Microb. Pathog. 29: 155-163.
40. Miyoshi, S., H. Watanabe, T. Kawase, H. Yamada, and S. Shinoda. 2004. Generation of active fragments from zymogens in the bradykinin-generating cascade by extracellular proteases from Vibrio vulnificus and V. parahaemolyticus. Toxicon 44: 887-893.
41. Miyoshi, N., S. Miyoshi, K. Sugiyama, Y. Suzuki, H. Furuta, and S. Shinoda. 1987. Activation of the plasma kallikrein-kinin system by Vibrio vulnificus protease. Infect. Immun. 55: 1936-1939.
42. Herwald, H., M. Collin, W. Müller-Esterl, and L. Björck. 1996. Streptococcal cysteine protease releases kinins: a novel virulence mechanism. J. Exp. Med. 184: 665-673.
43. Maruo, K., T. Akaike, Y. Inada, I. Ohkubo, T. Ono, and H. Maeda. 1993. Effect of microbial and mite proteases on low and high molecular weight kininogens: generation of kinin and inactivation of thiol protease inhibitory activity. J. Biol. Chem. 268: 17711-17715.
44. Chowdhury, M. A., S. Miyoshi, and S. Shinoda. 1991. Vascular permeability enhancement by Vibrio mimicus protease and the mechanisms of action. Microbiol. Immunol. 35: 1049-1058.
45. Maruo, K., T. Akaike, T. Ono, T. Okamoto, and H. Maeda. 1997. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease. J. Allergy Clin. Immunol 100: 253-260.
46. Wingrove, J. A., R. G. DiScipio, Z. Chen, J. Potempa, J. Travis, and T. E. Hugli. 1992. Activation of complement components C3 and C5 by a cysteine protease (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267: 18902-18907.
47. 2-macroglobulin on Vibrio vulnificus protease. J. Biochem. 106: 299-303.
48. 2- macroglobulin in the control of cysteine proteinases (gingipains) from Porphyromonas gingivalis. J. Periodontal Res. 32: 61-68.
49. 2-macroglobulin-like nature. Am. J. Pathol. 115: 57-69.
50. Leeb-Lundberg, L. M. F., F. Marceau, W. Müller-Esterl, D. J. Pettibone, and B. L. Zuraw. 2005. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 57: 27-77.
51. Husslein, V., H. Bergbauer, and T. Chakraborty. 1991. Studies on aerolysin and a serine protease from Aeromonas trota sp. nov. Experientia 47: 420-421.
52. Coleman, G., and P. W. Whitby. 1993. A comparison of amino acid sequence of the serine protease of the fish pathogen Aeromonas salmonicida with those of other subtilisin-type enzymes relative to their substrate-binding sites. J. Gen. Microbiol. 139: 245-249.
53. Esteve, C., and T. H. Birbeck. 2004. Secretion of haemolysins and proteases by Aeromonas hydrophila EO63: separation and characterization of the serine protease (caseinase) and the metalloprotease (elastase). J. Appl. Microbiol. 96: 994-1001.